Clinical Trial Update: Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of the bimatoprost/timolol fixed-dose combination in glaucoma or ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Ganfort (bimatoprost; timolol)

Snippet

Sponsor: Allergan | Conditions: Ocular Hypertension | Phase 3 | Status: COMPLETED